Sara Bigliardi Selected Research

Splenomegaly

1/2014

An unusual case of splenomegaly and increased lactate dehydrogenase heralding acute myeloid leukemia with eosinophilia and RUNX1-MECOM fusion transcripts.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sara Bigliardi Research Topics

Disease

3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2019 - 01/2014
2	Neoplasms (Cancer) 10/2019 - 01/2015
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2023
1	Hematologic Neoplasms (Hematological Malignancy) 10/2019
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 10/2019
1	Pathologic Complete Response 10/2019
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 03/2015
1	Mycoses (Diseases, Fungus) 01/2015
1	Eosinophilia 01/2014
1	Splenomegaly 01/2014

Drug/Important Bio-Agent (IBA)

1	Rituximab (Mabthera)FDA Link 01/2023
1	Bendamustine Hydrochloride FDA Link 01/2023
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023
1	Prednisone (Sone)FDA LinkGeneric 01/2023
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 12/2016
1	Cytarabine (Cytosar-U)FDA LinkGeneric 12/2016
1	Asparaginase (Elspar)FDA Link 03/2015
1	Sodium Glutamate (Accent)IBA 01/2015
1	Fungal DNAIBA 01/2015
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2014

Therapy/Procedure

2	Therapeutics 01/2023 - 10/2019
2	Drug Therapy (Chemotherapy) 10/2019 - 12/2016